Research and Markets has announced the addition of the "Bladder cancer Drugs Price Analysis and Strategies - 2016" report to their offering.
The latest research Bladder cancer Drugs Price Analysis and Strategies - 2016, provides drug pricing data and benchmarks in the global Bladder cancer market.
The research answers the following questions:
Bladder cancer Treatment Options - Identify key drugs marketed and prescribed for Bladder cancer in the US, Germany, France, Italy, Spain, UK, Japan including trade name, molecule name, and company
Bladder cancer Drugs Attributes - Find out the safety, efficacy, and risk benefit for key drugs marketed for Bladder cancer
Market Positioning - Identify how drugs are clinically and commercially positioned in the global Bladder cancer market
Bladder cancer Drugs Price Analysis - Find out the annual therapy cost and unit price for key drugs marketed for Bladder cancer in the US, Germany, France, Italy, Spain, UK, Japan. Find out how the price advanced from 2012 and forecast to 2021
Pricing & Reimbursement Landscape - Find out the pricing and reimbursement landscape in the US, Germany, France, Italy, Spain, UK, Japan
Bladder cancer New Drug Pricing - Identify the effective pricing strategy for a new drug launch in the US, Germany, France, Italy, Spain, UK, Japan
For more information about this report visit http://www.researchandmarkets.com/research/jml947/bladder_cancer
View source version on businesswire.com: http://www.businesswire.com/news/home/20161104005333/en/Business Wire
Last updated on: 04/11/2016
PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.